| 製品名 |
Frovatriptan Succinate |
| 英語名 |
Frovatriptan Succinate; Frovatriptan succinate; SB-209509ax; VML 251; 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1); 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, butanedioate (1:1); Butanedioic acid, compd. with (3R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide (1:1); (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide butanedioate (1:1) |
| 分子式 |
C18H23N3O5 |
| 分子量 |
361.3923 |
| InChI |
InChI=1/C14H17N3O.C4H6O4/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8)/t9-;/m1./s1 |
| CAS登録番号 |
158930-09-7 |
| 分子構造 |
|
| 沸点 |
515.2°C at 760 mmHg |
| 引火点 |
265.4°C |
| 蒸気圧 |
1.01E-10mmHg at 25°C |
| ハザードシンボル |
|
| リスクコード |
|
| 安全説明 |
|
|
